Webcasts & Presentations

Neurocrine’s management team participates in industry conferences providing presentations on company updates and progress on research and development activities. The company conducts webcasts and conference calls for these conferences and provides financial highlights and company news updates during regularly scheduled conference calls. For questions or information on current or future webcasts and conference calls contact ir@neurocrine.com

Neurocrine Presents at Goldman Sachs 38th Annual Global Healthcare Conference in Rancho Palos Verdes, CA
June 15, 2017  at 9:20amPT (12:20pmET)
Goldman Sachs Webcast  –
Accompanying slides are available by clicking (on this webpage) “CORPORATE PRESENTATION (PDF).  This link is used for real-time and archive audio through July 15, 2017

Neurocrine Presents at the Jefferies 2017 Global Healthcare Conference
June 8 at 1:30pm ET (10:30am PT)
Jefferies Conf Webcast  –
This audio link is used for real-time and archive through July 8, 2017

Neurocrine Announces PhII Results of VMAT2 Inhibitor INGREZZA® for Treatment of Tourette Syndrome
May 23, 2017 at 5:00pm ET (2:00pm PT)
INGREZZA Tourette WebcastThis link is used for real-time and archive audio through June 23, 2017

CORPORATE PRESENTATION (PDF) This presentation provides an overview of our company pipeline, program progress, and financial highlights.